Back to Search Start Over

Thyroid-Stimulating Hormone Receptor Antibodies in Refractory Graves’ Disease Change Differently According to the Type of Definitive Therapy Administered

Authors :
Ulla Feldt-Rasmussen
Source :
Clinical Thyroidology. 33:350-353
Publication Year :
2021
Publisher :
Mary Ann Liebert Inc, 2021.

Subjects

Subjects :
medicine.medical_specialty
biology
business.industry
Graves' disease
Definitive Therapy
General Medicine
medicine.disease
Gastroenterology
Thyroid stimulating hormone receptor
Refractory
Internal medicine
biology.protein
Medicine
Antibody
business

Details

ISSN :
2329972X and 23299711
Volume :
33
Database :
OpenAIRE
Journal :
Clinical Thyroidology
Accession number :
edsair.doi...........d93e26b8c14c5f9632d481eef5f48007

Tools

Authors Abstract Subjects Details